{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:22:20Z","timestamp":1790767340912,"version":"4.1.0"},"reference-count":34,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T00:00:00Z","timestamp":1532908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Pulmonary hypertension is a co-morbidity, which strongly participates in morbi-mortality in patients with chronic obstructive pulmonary disease (COPD). Recent findings showed that bromodomain-containing proteins, in charge of reading histone acetylation, could be involved in pulmonary arterial hypertension. Our aim was to study the effect of I-BET151, an inhibitor of bromodomain and extra-terminal domain (BET), on the right ventricle hypertrophy and pulmonary hypertension, induced by a combination of chronic hypoxia and pulmonary inflammation, as the two main stimuli encountered in COPD. Adult Wistar male rats, exposed to chronic hypoxia plus pulmonary inflammation (CHPI), showed a significant right ventricle hypertrophy (+57%, p &lt; 0.001), an increase in systolic pressure (+46%, p &lt; 0.001) and in contraction speed (+36%, p &lt; 0.001), when compared to control animals. I-BET151 treated animals (CHPI-iB) showed restored hemodynamic parameters to levels similar to control animals, despite chronic hypoxia plus exposure to pulmonary inflammation. They displayed lower right ventricle hypertrophy and hematocrit compared to the CHPI group (respectively \u221216%, p &lt; 0.001; and \u22129%, p &lt; 0.05). Our descriptive study shows a valuable effect of the inhibition of bromodomain and extra-terminal domain proteins on hemodynamic parameters, despite the presence of chronic hypoxia and pulmonary inflammation. This suggests that such inhibition could be of potential interest for COPD patients with pulmonary hypertension. Further studies are needed to unravel the underlying mechanisms involved and the net benefits of inhibiting adaptations to chronic hypoxia.<\/jats:p>","DOI":"10.3390\/ijms19082224","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T11:55:08Z","timestamp":1532951708000},"page":"2224","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Inhibition of BET Proteins Reduces Right Ventricle Hypertrophy and Pulmonary Hypertension Resulting from Combined Hypoxia and Pulmonary Inflammation"],"prefix":"10.3390","volume":"19","author":[{"given":"Clovis","family":"Chabert","sequence":"first","affiliation":[{"name":"Universit\u00e9 Grenoble Alpes, Inserm U1055, Laboratoire de Bio\u00e9nerg\u00e9tique Fondamentale et Appliqu\u00e9e, 38058 Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadi","family":"Khochbin","sequence":"additional","affiliation":[{"name":"CNRS UMR 5309, Inserm U1209, Universit\u00e9 Grenoble Alpes, Institute for Advanced Biosciences, 38700 Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Rousseaux","sequence":"additional","affiliation":[{"name":"CNRS UMR 5309, Inserm U1209, Universit\u00e9 Grenoble Alpes, Institute for Advanced Biosciences, 38700 Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2894-3820","authenticated-orcid":false,"given":"Sylvie","family":"Veyrenc","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Grenoble Alpes, CNRS UMR 5553, Laboratoire d\u2019Ecologie Alpine, 38058 Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Furze","sequence":"additional","affiliation":[{"name":"Epigenetics DPU, Immuno-Inflammation Therapy Area, GlaxoSmithKline R&amp;D, Medicines Research Centre, Stevenage SG1 2NY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Smithers","sequence":"additional","affiliation":[{"name":"Epigenetics DPU, Immuno-Inflammation Therapy Area, GlaxoSmithKline R&amp;D, Medicines Research Centre, Stevenage SG1 2NY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rab K","family":"Prinjha","sequence":"additional","affiliation":[{"name":"Epigenetics DPU, Immuno-Inflammation Therapy Area, GlaxoSmithKline R&amp;D, Medicines Research Centre, Stevenage SG1 2NY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1159-5911","authenticated-orcid":false,"given":"Uwe","family":"Schlattner","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Grenoble Alpes, Inserm U1055, Laboratoire de Bio\u00e9nerg\u00e9tique Fondamentale et Appliqu\u00e9e, 38058 Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Pison","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Grenoble Alpes, Inserm U1055, Laboratoire de Bio\u00e9nerg\u00e9tique Fondamentale et Appliqu\u00e9e, 38058 Grenoble, France"},{"name":"Centre Hospitalier Universitaire Grenoble Alpes, Universit\u00e9 Grenoble Alpes, 38700 Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1268-6110","authenticated-orcid":false,"given":"Herv\u00e9","family":"Dubouchaud","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Grenoble Alpes, Inserm U1055, Laboratoire de Bio\u00e9nerg\u00e9tique Fondamentale et Appliqu\u00e9e, 38058 Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,7,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S2213-2600(15)00542-1","article-title":"Treatment of pulmonary hypertension","volume":"4","author":"Hoeper","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1183\/09031936.00015608","article-title":"Pulmonary hypertension in COPD","volume":"32","author":"Chaouat","year":"2008","journal-title":"Eur. Respir. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40248-015-0023-2","article-title":"Prevalence of different comorbidities in COPD patients by gender and GOLD stage","volume":"10","author":"Bonadiman","year":"2015","journal-title":"Multidiscip. Respir. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1183\/09031936.00128706","article-title":"The effects of hypoxia on the cells of the pulmonary vasculature","volume":"30","author":"Pak","year":"2007","journal-title":"Eur. Respir. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.physiol.59.1.89","article-title":"Cellular and molecular mechanisms of pulmonary vascular remodeling","volume":"59","author":"Stenmark","year":"1997","journal-title":"Annu. Rev. Phys."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1465-9921-11-63","article-title":"Systemic inflammation in chronic obstructive pulmonary disease: A population-based study","volume":"11","author":"Miravitlles","year":"2010","journal-title":"Respir. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"L229","DOI":"10.1152\/ajplung.00238.2014","article-title":"The role of inflammation in hypoxic pulmonary hypertension: From cellular mechanisms to clinical phenotypes","volume":"308","author":"Pugliese","year":"2015","journal-title":"Am. J. Physiol. Lung. Cell Mol. Physiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/cpr.12076","article-title":"Role of histone deacetylases in regulation of phenotype of ovine newborn pulmonary arterial smooth muscle cells","volume":"46","author":"Yang","year":"2013","journal-title":"Cell Prolif."},{"key":"ref_9","first-page":"760","article-title":"Sodium valproate, a histone deacetylase inhibitor, but not captopril, prevents right ventricular hypertrophy in rats","volume":"74","author":"Cho","year":"2010","journal-title":"Circ. J. Off. J. Jpn. Circ. Soc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/CIRCRESAHA.111.258426","article-title":"Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism","volume":"110","author":"Cavasin","year":"2012","journal-title":"Circ. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCULATIONAHA.112.103176","article-title":"Histone deacetylation inhibition in pulmonary hypertension: Therapeutic potential of valproic acid and suberoylanilide hydroxamic acid","volume":"126","author":"Zhao","year":"2012","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1139\/bcb-2014-0119","article-title":"Acetyl-lysine erasers and readers in the control of pulmonary hypertension and right ventricular hypertrophy","volume":"93","author":"Stratton","year":"2015","journal-title":"Biochem. Cell Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/CIRCRESAHA.115.307004","article-title":"Bromodomain-Containing Protein 4: The Epigenetic Origin of Pulmonary Arterial Hypertension","volume":"117","author":"Meloche","year":"2015","journal-title":"Circ. Res."},{"key":"ref_14","first-page":"1171","article-title":"A novel murine model of severe pulmonary arterial hypertension","volume":"184","author":"Ciuclan","year":"2011","journal-title":"Am. J. Physiol. Lung. Cell Mol. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.3390\/ijms12074705","article-title":"Epigenetics: New questions on the response to hypoxia","volume":"12","author":"Acevedo","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/0022034510378683","article-title":"Epigenetic mechanisms in inflammation","volume":"90","author":"Bayarsaihan","year":"2011","journal-title":"J. Dent. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1042\/CS20140428","article-title":"Quadriceps muscle weakness and atrophy are associated with a differential epigenetic profile in advanced COPD","volume":"128","author":"Ausin","year":"2015","journal-title":"Clin. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.pharmthera.2007.06.009","article-title":"Impact of protein acetylation in inflammatory lung diseases","volume":"116","author":"Ito","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"ref_19","first-page":"1402","article-title":"Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats","volume":"183","author":"Bogaard","year":"2011","journal-title":"Am. J. Physiol. Lung. Cell Mol. Physiol."},{"key":"ref_20","first-page":"699","article-title":"Cyclosporin A inhibits hypoxia-induced pulmonary hypertension and right ventricle hypertrophy","volume":"174","author":"Koulmann","year":"2006","journal-title":"Am. J. Physiol. Lung. Cell Mol. Physiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1086\/678508","article-title":"The Sugen 5416\/hypoxia mouse model of pulmonary hypertension revisited: Long-term follow-up","volume":"4","author":"Vitali","year":"2014","journal-title":"Pulm. Circ."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"L1013","DOI":"10.1152\/ajplung.00217.2009","article-title":"Animal models of pulmonary arterial hypertension: The hope for etiological discovery and pharmacological cure","volume":"297","author":"Stenmark","year":"2009","journal-title":"Am. J. Physiol. Lung. Cell Mol. Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1242\/dmm.003616","article-title":"Idiopathic pulmonary arterial hypertension","volume":"3","author":"Firth","year":"2010","journal-title":"Dis. Models Mech."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1172\/JCI118228","article-title":"Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension","volume":"96","author":"Morrell","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.pupt.2009.01.004","article-title":"Potential effects of peroxisome proliferator-activated receptor activator on LPS-induced lung injury in rats","volume":"22","author":"Wang","year":"2009","journal-title":"Pulmon. Pharmacol. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1165\/ajrcmb.26.1.4652","article-title":"Long-term intratracheal lipopolysaccharide exposure in mice results in chronic lung inflammation and persistent pathology","volume":"26","author":"Vernooy","year":"2002","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"12133","DOI":"10.1038\/s41598-017-12112-0","article-title":"Muscle hypertrophy in hypoxia with inflammation is controlled by bromodomain and extra-terminal domain proteins","volume":"7","author":"Chabert","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_28","first-page":"97","article-title":"Regulation of oxygen homeostasis by hypoxia-inducible factor 1","volume":"24","author":"Semenza","year":"2009","journal-title":"Physiology (Bethesda)"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm.3587","article-title":"An acetate switch regulates stress erythropoiesis","volume":"20","author":"Xu","year":"2014","journal-title":"Nat. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1158\/1541-7786.MCR-11-0053","article-title":"Differential hypoxic regulation of hypoxia-inducible factors 1\u03b1 and 2\u03b1","volume":"9","author":"Lin","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0002-9343(75)90538-0","article-title":"Hemodynamic effects of staged hematocrit reduction in patients with stable cor pulmonale and severely elevated hematocrit levels","volume":"58","author":"Weisse","year":"1975","journal-title":"Am. J. Med."},{"key":"ref_32","first-page":"225","article-title":"Repetitive hemodilution in chronic obstructive pulmonary disease and pulmonary hypertension: Effects on pulmonary hemodynamics, gas exchange, and exercise capacity","volume":"66","author":"Borst","year":"1999","journal-title":"Respir. Int. Rev. Thorac. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"H2132","DOI":"10.1152\/ajpheart.00405.2004","article-title":"Mabley, J.G. Liaudet, L. Evgenov, O.V. Marton, A. Hask\u00f3, G. Kollai, M. Szab\u00f3, C. Left ventricular pressure-volume relationship in a rat model of advanced aging-associated heart failure","volume":"287","author":"Pacher","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"Galie","year":"2016","journal-title":"Eur. Heart J."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/8\/2224\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:15:17Z","timestamp":1760195717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/8\/2224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,30]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8]]}},"alternative-id":["ijms19082224"],"URL":"https:\/\/doi.org\/10.3390\/ijms19082224","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,30]]}}}